![]() |
市場調查報告書
商品編碼
1493512
細胞分選市場 - 全球產業規模、佔有率、趨勢、機會和預測,按產品和服務、技術、應用、最終用戶、地區和競爭細分,2019-2029FCell Sorting Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Services, By Technology, By Application, By End User, By Region, and By Competition, 2019-2029F |
2023 年,全球細胞分選市場價值為4.5138 億美元,到2029 年,預測期內將以5.62% 的複合年成長率實現令人印象深刻的成長。從異質混合物中分離並隔離特定細胞群。它允許研究人員分析和操作單一細胞或細胞群,用於各種生物學、生物醫學和臨床應用。細胞分選的第一步涉及製備含有異質細胞混合物的樣品。樣本可包括源自組織、血液、細胞培養物或其他生物樣本的細胞懸浮液。樣本可以用螢光染料、抗體或分子探針處理,以標記特定的細胞類型或感興趣的標記。細胞分選是使用稱為細胞分選儀的專用儀器進行的。這些儀器利用不同的分選方法,包括螢光激活細胞分選 (FACS)、磁激活細胞分選 (MACS) 和基於微流體的分選,根據大小、形狀、粒度和螢光等特定特徵分離目標細胞強度。細胞分選實驗需要根據目標細胞群的特定特徵定義分選標準和參數。研究人員建立螢光強度、散射特性或其他表現型標記的分選門或閾值,以識別和分離感興趣的細胞,同時排除不必要的細胞群。
市場概況 | |
---|---|
預測期 | 2025-2029 |
2023 年市場規模 | 4.5138億美元 |
2029 年市場規模 | 61874萬美元 |
2024-2029 年複合年成長率 | 5.62% |
成長最快的細分市場 | 細胞分選儀 |
最大的市場 | 北美洲 |
細胞分選技術的不斷進步,包括分選速度、解析度、靈敏度和多參數分析的改進,透過擴展細胞分選平台的功能和應用來推動市場成長。技術創新使研究人員能夠以前所未有的精確度和效率進行複雜的實驗、分析細胞異質性並分離特定的細胞群。細胞分選技術廣泛應用於生物醫學研究應用,包括免疫學、腫瘤學、幹細胞生物學、神經科學和藥物發現。基礎研究、生物標記發現、單細胞分析和臨床前研究對細胞分選解決方案的需求不斷成長,推動了市場成長,並推動了專業分選平台和試劑開發的創新。單細胞分析技術(包括單細胞定序、轉錄組分析和蛋白質組分析)的出現推動了對能夠分離單一細胞或小細胞群以進行下游分析的細胞分選平台的需求。研究人員利用單細胞分析技術來研究細胞異質性、識別稀有細胞群並闡明疾病機制,從而推動市場成長和細胞分選技術的創新。
細胞分選技術的進步
擴大生物醫學研究中的應用
單細胞分析技術的日益採用
樣本異質性和變異性
細胞受損和喪失活力的風險
再生醫學和細胞治療研究的興起
應用洞察
最終使用者見解
區域洞察
Global Cell Sorting Market was valued at USD 451.38 million in 2023 and will see an impressive growth in the forecast period at a CAGR of 5.62% through 2029. Cell sorting is a laboratory technique used to separate and isolate specific cell populations from a heterogeneous mixture of cells based on their physical, biochemical, or functional properties. It allows researchers to analyze and manipulate individual cells or cell populations for various biological, biomedical, and clinical applications. The first step in cell sorting involves preparing the sample containing the heterogeneous mixture of cells. Samples can include cell suspensions derived from tissues, blood, cell cultures, or other biological specimens. The sample may be treated with fluorescent dyes, antibodies, or molecular probes to label specific cell types or markers of interest. Cell sorting is performed using specialized instruments known as cell sorters. These instruments utilize different sorting methods, including fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and microfluidics-based sorting, to isolate target cells based on specific characteristics such as size, shape, granularity, and fluorescence intensity. Cell sorting experiments require defining sorting criteria and parameters based on the specific characteristics of the target cell population. Researchers establish sorting gates or thresholds for fluorescence intensity, scatter properties, or other phenotypic markers to identify and isolate cells of interest while excluding unwanted cell populations.
Market Overview | |
---|---|
Forecast Period | 2025-2029 |
Market Size 2023 | USD 451.38 Million |
Market Size 2029 | USD 618.74 Million |
CAGR 2024-2029 | 5.62% |
Fastest Growing Segment | Cell Sorters |
Largest Market | North America |
Continuous advancements in cell sorting technologies, including improvements in sorting speed, resolution, sensitivity, and multiparametric analysis, drive market growth by expanding the capabilities and applications of cell sorting platforms. Technological innovations enable researchers to perform complex experiments, analyze cellular heterogeneity, and isolate specific cell populations with unprecedented precision and efficiency. Cell sorting techniques are utilized across a wide range of biomedical research applications, including immunology, oncology, stem cell biology, neuroscience, and drug discovery. The increasing demand for cell sorting solutions in basic research, biomarker discovery, single-cell analysis, and preclinical studies fuels market growth and drives innovation in the development of specialized sorting platforms and reagents. The emergence of single-cell analysis technologies, including single-cell sequencing, transcriptomic profiling, and proteomic analysis, drives the demand for cell sorting platforms capable of isolating individual cells or small cell populations for downstream analysis. Researchers utilize single-cell analysis techniques to study cellular heterogeneity, identify rare cell populations, and elucidate disease mechanisms, driving market growth and innovation in cell sorting technologies.
Key Market Drivers
Advancements in Technology in Cell Sorting
Modern cell sorting platforms incorporate advanced fluidics systems, optimized nozzle designs, and high-speed electronics to achieve rapid sorting rates, enabling the processing of large cell populations within a short timeframe. High-speed sorting capabilities improve workflow efficiency and throughput in cell sorting experiments, facilitating high-throughput screening and analysis of diverse cell samples. Advancements in fluorescence detection systems and optical design enable multiparametric analysis of cells based on multiple fluorescent markers and parameters simultaneously. Multi-laser configurations, spectral detection capabilities, and advanced signal processing algorithms allow researchers to characterize cellular phenotypes, identify rare cell populations, and analyze complex cell mixtures with high resolution and specificity. Single cell sorting technologies have revolutionized the study of cellular heterogeneity and functional diversity within complex biological systems. Microfluidic-based sorting platforms, integrated with microvalve arrays and precise control mechanisms, enable the isolation and manipulation of individual cells or small cell populations for downstream single-cell analysis techniques, including single-cell sequencing, transcriptomic profiling, and proteomic analysis. Gentle sorting methods minimize cell stress and preserve cell viability and functionality during the sorting process, particularly for fragile or sensitive cell types. Sheathless sorting systems, acoustic-based sorting techniques, and microfluidic sorting platforms offer gentle handling and precise control over sorting parameters, ensuring the integrity and viability of sorted cells for downstream applications in cell biology, regenerative medicine, and therapeutic development.
Integration of automation and robotics technologies streamlines workflow automation, reduces manual intervention, and enhances reproducibility in cell sorting experiments. Automated sample preparation, cell dispensing, and sorting protocols improve efficiency, accuracy, and consistency in sorting workflows, enabling researchers to process large-scale experiments, screen compound libraries, and analyze cellular responses with minimal user intervention. Advanced data analysis software tools and algorithms facilitate real-time data acquisition, analysis, and visualization during cell sorting experiments. Customizable gating strategies, machine learning algorithms, and population identification tools enable researchers to extract meaningful insights from complex cytometric data, identify rare cell populations, and characterize cellular phenotypes with greater accuracy and efficiency. Microfluidics-based sorting platforms leverage microscale fluid dynamics and precise control mechanisms to achieve high-resolution sorting of cells and particles. Microfluidic sorting systems offer advantages such as reduced sample and reagent consumption, enhanced sorting accuracy, and compatibility with lab-on-a-chip devices, enabling miniaturization, integration, and multiplexing of sorting assays for diverse research applications. This factor will help in the development of the Global Cell Sorting Market.
Expanding Applications in Biomedical Research
Biomedical researchers are increasingly interested in understanding the heterogeneity of cellular populations within tissues and organs. Cell sorting allows researchers to isolate specific cell types or subpopulations based on surface markers, intracellular molecules, or functional characteristics. This capability enables the study of cellular heterogeneity in normal physiology and disease states, providing insights into cellular function, differentiation pathways, and disease mechanisms. Cell sorting techniques are essential for identifying and validating biomarkers associated with various diseases, including cancer, autoimmune disorders, and infectious diseases. By isolating rare cell populations or subpopulations with specific biomarker expression profiles, researchers can elucidate disease-specific signatures, identify diagnostic markers, and develop targeted therapies tailored to individual patients' molecular profiles. Cell sorting plays a crucial role in stem cell biology and regenerative medicine by enabling the isolation and purification of stem cell populations from heterogeneous tissues. Researchers use cell sorting techniques to identify and characterize stem cells based on surface markers, lineage-specific markers, and functional assays. Isolated stem cells can be further differentiated into specialized cell types for tissue engineering, organ transplantation, and disease modeling applications. In immunology research, cell sorting is used to isolate immune cell subsets, such as T cells, B cells, dendritic cells, and macrophages, for functional studies, antigen-specific assays, and immune profiling. Cell sorting technologies contribute to vaccine development efforts by enabling the characterization of immune responses, identification of antigen-specific cell populations, and evaluation of vaccine efficacy in preclinical and clinical studies.
Cell sorting is integral to drug discovery and target identification processes in pharmaceutical and biotechnology research. Researchers use cell sorting platforms to screen compound libraries, identify drug targets, and assess compound efficacy and toxicity in relevant cellular models. By isolating specific cell populations associated with disease pathology or therapeutic response, researchers can prioritize drug candidates and accelerate the drug discovery pipeline. Advances in single-cell analysis technologies, such as single-cell sequencing, transcriptomic profiling, and proteomic analysis, have fueled the demand for cell sorting platforms capable of isolating individual cells or small cell populations for downstream analysis. Single-cell analysis techniques enable researchers to explore gene expression patterns, signaling pathways, and functional interactions at the single-cell level, providing insights into cellular heterogeneity and disease pathogenesis. Cell sorting technologies are increasingly used in clinical diagnostics and personalized medicine applications to stratify patient populations, monitor disease progression, and guide treatment decisions. By analyzing circulating tumor cells, immune cells, or stem cells from patient samples, clinicians can assess disease prognosis, predict treatment responses, and tailor therapeutic strategies to individual patient profiles. This factor will pace up the demand of the Global Cell Sorting Market.
Growing Adoption of Single-Cell Analysis Technologies
Single-cell analysis techniques require the isolation and characterization of individual cells or small cell populations for downstream analysis. Cell sorting enables researchers to isolate specific cells of interest based on their phenotypic or functional characteristics, facilitating the study of cellular heterogeneity, gene expression dynamics, and functional diversity at the single-cell level. Single-cell analysis technologies demand high-resolution and high-sensitivity methods for isolating individual cells with precision and accuracy. Cell sorting platforms equipped with advanced fluorescence detection systems, multiparametric analysis capabilities, and precise sorting algorithms enable researchers to identify and isolate rare cell populations, distinguish between cell subtypes, and analyze cellular phenotypes with unparalleled sensitivity and resolution. Single-cell analysis techniques, such as single-cell RNA sequencing (scRNA-seq), single-cell ATAC-seq, and single-cell proteomics, rely on the isolation of individual cells for genomic, epigenomic, and proteomic profiling. Cell sorting facilitates the isolation of homogeneous cell populations for single-cell sequencing and omics analysis, enabling researchers to explore gene expression patterns, identify cell state transitions, and elucidate regulatory networks at the single-cell level.
Single-cell analysis technologies enable researchers to investigate cellular heterogeneity and functional diversity within complex biological systems. By analyzing individual cells from heterogeneous populations, researchers can identify rare cell subsets, characterize cell-to-cell variability, and elucidate cell signaling pathways, contributing to a deeper understanding of developmental processes, disease progression, and therapeutic responses. Microfluidics-based cell sorting platforms offer precise control over fluid dynamics, enabling the isolation of individual cells or small cell populations with minimal sample contamination and cell stress. These platforms integrate seamlessly with single-cell analysis workflows, allowing researchers to perform high-throughput sorting and downstream analysis of single cells in a streamlined and efficient manner. Single-cell analysis technologies have diverse applications in biomedical research, clinical diagnostics, and personalized medicine. Researchers use single-cell sequencing and omics techniques to study cancer heterogeneity, immune cell diversity, neuronal circuitry, and developmental processes. In clinical diagnostics, single-cell analysis enables the identification of disease biomarkers, monitoring of disease progression, and prediction of treatment responses in patient samples. This factor will accelerate the demand of the Global Cell Sorting Market.
Key Market Challenges
Sample Heterogeneity and Variability
Biological samples, such as tissues, blood, or cell cultures, often exhibit inherent heterogeneity and variability in terms of cell size, shape, morphology, and fluorescence intensity. This complexity poses challenges for cell sorting procedures, as the target cell populations may be present in low abundance or exhibit overlapping characteristics with non-target cells. Identifying and isolating specific cell populations from heterogeneous samples can be challenging due to the presence of background noise, autofluorescence, and nonspecific binding of fluorescent labels. Variability in the expression levels of surface markers or intracellular molecules further complicates the identification and sorting of target cells, leading to decreased sorting efficiency and purity. Conventional cell sorting techniques may have limitations in resolving subtle differences in cell phenotypes or functional states within heterogeneous populations. As a result, certain cell subsets or rare cell populations may be missed or improperly sorted, leading to incomplete or inaccurate analysis of the sample and potential loss of valuable information. Sample heterogeneity and variability can introduce bias and artifacts in cell sorting experiments, affecting the reliability and reproducibility of downstream data analysis and interpretation. Variations in sorting parameters, instrument settings, and sample preparation methods may influence sorting outcomes and complicate the comparison of results across different experiments or research studies.
Risk of Cell Damage and Loss of Viability
Cell sorting involves subjecting cells to various mechanical, hydrodynamic, and optical forces during the sorting process. These forces can potentially damage cells or compromise their integrity, leading to changes in cell morphology, membrane integrity, and functionality. Maintaining cellular viability and preserving biological integrity are critical considerations in cell sorting experiments, especially when working with sensitive or delicate cell types. Cells experience shear stress and fluidic forces as they pass through the sorting system's fluidic channels and nozzle. High shear rates and turbulent flow conditions can induce mechanical stress on cells, causing membrane rupture, cytoskeletal damage, or cellular fragmentation. Minimizing shear stress and optimizing flow parameters are essential for reducing cell damage and preserving viability during sorting procedures. Fluorescent labeling and laser illumination used in fluorescence-activated cell sorting (FACS) systems can induce photo-damage and phototoxicity in sorted cells, particularly when exposed to high-intensity light sources or prolonged irradiation. Photo-induced cellular damage may lead to DNA damage, protein denaturation, or oxidative stress, adversely affecting cell viability and functionality. Temperature fluctuations and environmental conditions within the sorting instrument can impact cell viability and sorting performance. Variations in temperature, pH, osmolarity, and oxygen levels can influence cellular metabolism, energy production, and stress response pathways, affecting cell viability and recovery rates post-sorting.
Key Market Trends
Rise in Regenerative Medicine and Cell Therapy Research
Regenerative medicine and cell therapy research often involve the identification, isolation, and characterization of specific cell populations with regenerative or therapeutic potential. Cell sorting technologies enable researchers to isolate and purify stem cells, progenitor cells, and other specialized cell types from heterogeneous tissues or cell cultures, facilitating the development of cell-based therapies and regenerative medicine approaches. Cell sorting plays a crucial role in stem cell research and tissue engineering by enabling the isolation and enrichment of pluripotent stem cells or lineage-specific progenitor cells for tissue regeneration and repair. Researchers utilize cell sorting techniques to identify and characterize stem cell populations, evaluate their differentiation potential, and engineer functional tissues and organs for transplantation and regenerative therapy applications. The emergence of cell-based therapies, including cell transplantation, immunotherapy, and gene therapy, has spurred the demand for cell sorting technologies in the development and manufacturing of therapeutic products. Cell sorting enables the selection and purification of therapeutic cell populations, such as mesenchymal stem cells, hematopoietic stem cells, and immune effector cells, for clinical applications in treating various diseases and disorders, including cancer, autoimmune diseases, and degenerative conditions. Cell sorting technologies are essential for ensuring the quality, purity, and safety of cell-based therapies and regenerative medicine products. Regulatory agencies require stringent quality control measures and standardized manufacturing processes to ensure the reproducibility, consistency, and safety of therapeutic cell products. Cell sorting platforms facilitate the isolation of homogeneous cell populations, removal of contaminants, and enrichment of therapeutic cell subsets, meeting regulatory requirements and industry standards for cell manufacturing and transplantation.
Segmental Insights
Application Insights
Based on the application, the research segment is projected to experience significant growth in the Global Cell Sorting Market during the forecast period. Cell sorting technologies are widely used in basic research across various scientific disciplines, including immunology, oncology, stem cell biology, neuroscience, and microbiology. Researchers rely on cell sorting techniques to isolate and analyze specific cell populations, investigate cellular heterogeneity, elucidate molecular mechanisms, and study disease pathogenesis, driving demand for advanced cell sorting platforms and services in the research community. The emergence of single-cell analysis technologies has revolutionized the study of cellular heterogeneity and functional diversity within complex biological systems. Cell sorting enables researchers to isolate individual cells or defined cell subsets for downstream single-cell sequencing, transcriptomic profiling, epigenetic analysis, and functional assays, providing valuable insights into cell-to-cell variability and contributing to advancements in systems biology and personalized medicine. Cell sorting plays a crucial role in genomic and proteomic studies by facilitating the isolation of specific cell types for genomic sequencing, gene expression analysis, protein profiling, and biomarker discovery. Researchers utilize cell sorting techniques to enrich rare cell populations, identify disease-associated genetic variants, characterize signaling pathways, and elucidate the molecular basis of disease, driving growth in research applications of cell sorting technologies.
End User Insights
Based on the end user, the Pharmaceutical and Biotechnology Companies segment is projected to experience significant growth in the Global Cell Sorting Market during the forecast period. Pharmaceutical and biotechnology companies are investing heavily in drug discovery and development to address unmet medical needs, including complex diseases such as cancer, autoimmune disorders, and infectious diseases. Cell sorting technologies play a crucial role in identifying therapeutic targets, characterizing drug candidates, and conducting preclinical and clinical studies, driving demand for advanced cell sorting platforms and services. The growing popularity of biologics, including monoclonal antibodies, recombinant proteins, and cell-based therapies, has fueled the demand for cell sorting technologies. Pharmaceutical and biotechnology companies are leveraging cell sorting techniques to isolate and characterize specific cell populations to produce biologics, as well as to develop novel cell-based therapies for various indications, driving market growth in this segment. High-throughput screening (HTS) technologies, including cell sorting, are increasingly being adopted by pharmaceutical and biotechnology companies to accelerate the drug discovery process. Cell sorting platforms enable researchers to screen large libraries of compounds, identify lead molecules, and assess drug efficacy and toxicity in a high-throughput manner, enhancing efficiency and productivity in drug discovery workflows.
Regional Insights
North America emerged as the dominant player in the Global Cell Sorting Market in 2023. North America, particularly the United States, boasts a robust research and development infrastructure supported by leading academic institutions, research organizations, and biotechnology companies. The region's extensive network of research facilities fosters innovation and drives advancements in cell sorting technologies. North America has one of the highest healthcare expenditures globally, with substantial investments in biomedical research, clinical diagnostics, and therapeutic development. The availability of funding and resources facilitates the adoption of cutting-edge technologies, including advanced cell sorting platforms, in both academic and clinical settings. Many prominent companies operating in the cell sorting market are headquartered or have a significant presence in North America. These companies leverage the region's scientific expertise, technological capabilities, and market demand to develop and commercialize innovative cell sorting solutions tailored to the needs of researchers and healthcare professionals.
Sony Biotechnology Inc.
Union Biometrica, Inc.
TERUMO BCT, Inc.
Sysmex Europe SE.
Beckton, and Dickinson Company
Bio-Rad Laboratories, Inc.
Cytonome/ST, LLC
On-chip Biotechnologies Co., Ltd
Beckman Coulter, Inc
Thermo Fisher Scientific Inc.
In this report, the Global Cell Sorting Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Immunology & Cancer Research
Stem Cell Research
Drug Discovery
Others
United States
Canada
Mexico
Germany
United Kingdom
France
Italy
Spain
China
Japan
India
Australia
South Korea
Brazil
Argentina
Colombia
South Africa
Saudi Arabia
UAE
Company Profiles: Detailed analysis of the major companies present in the Global Cell Sorting Market.
Global Cell Sorting market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to five).